Latest Advances

  • Condition: Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Rituximab Dosing in R-CHOP Therapy
  • Number of Patients: 0
  • Published —
This article discusses the rituximab dosing schedule in R-CHOP therapy for the treatment of patients with diffuse large B-cell lymphoma (DLBCL).
  • Condition: Chylothorax in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Lymphangiography
  • Number of Patients: 1
  • Published —
This case report describes a 59-year-old woman diagnosed with diffuse large B-cell lymphoma (DLBCL) with chylothorax (lymph fluid in chest cavity) treated with lymphangiography.
  • Condition: Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: Blood cancer journal
  • Treatment Used: Prophylaxis with Intrathecal or High-Dose Methotrexate (MTX)
  • Number of Patients: 585
  • Published —
This study examined the effectiveness of different prophylactic methotrexate (MTX) regimens in the treatment of patients with diffuse large B-cell lymphoma (DLBCL) and high-risk for central nervous system (CNS) relapse.
  • Condition: Triple-Hit Refractory/Relapsed Diffuse Large B-Cell Lymphoma (RR DLBCL)
  • Journal: Frontiers in immunology
  • Treatment Used: Generated CAR19-T Cells Plus Lenalidomide
  • Number of Patients: 0
  • Published —
This case report describes a patient diagnosed with triple-hit lymphoma (THL) refractory/relapsed diffuse large B cell lymphoma (RR DLBCL) treated with generated CAR19-T cells plus lenalidomide.
  • Condition: Synchronous Lymphoma, Pancreatic Neuroendocrine Tumor, and Colorectal Cancer
  • Journal: BMJ case reports
  • Treatment Used: Low Rectal Endoscopic Excision, R-CHOP Chemotherapy, and Laparoscopic Left Pancreatectomy
  • Number of Patients: 1
  • Published —
This case report describes a 67-year-old woman diagnosed with synchronous lymphoma, pancreatic neuroendocrine tumor, and colorectal cancer treated with low rectal endoscopic excision, R-CHOP chemotherapy, and laparoscopic left pancreatectomy.
  • Condition: Elderly Patients with Diffuse Large B-cell Lymphoma (DLBCL)
  • Journal: Blood advances
  • Treatment Used: Reduced Dose Intensity (DI) of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone+Rituximab (R-CHOP)
  • Number of Patients: 5188
  • Published —
This study evaluated the impact of reduced dose intensity (DI) of cyclophosphamide, doxorubicin, vincristine, and prednisolone+rituximab (R-CHOP) in elderly patients with diffuse large B-cell lymphoma (a cancer of B cells; DLBCL).
  • Condition: Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: Frontiers in immunology
  • Treatment Used: Combined Intravenous Infusion and Local Injection of CAR-T Cells
  • Number of Patients: 0
  • Published —
This case report describe a patient with relapsed diffuse large B-cell lymphoma (DLBCL) treated with combining intravenous infusion with local injection of CAR-T cells.
  • Journal: Journal of medical case reports
  • Published —
Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report.
  • Condition: Japanese Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: Cancer science
  • Treatment Used: Polatuzumab Vedotin Plus Bendamustine Plus Rituximab
  • Number of Patients: 35
  • Published —
This study evaluated polatuzumab vedotin plus bendamustine plus rituximab in the treatment of Japanese patients with relapsed/refractory diffuse large B-cell lymphoma.
Showing 1-12 of 254